Both AKT and JNK inhibition blocked EDN‐induced glioma cell migration (Hsieh et al, 2014), and AKT inhibition prevented EDNRA‐mediated migration of hepatocellular carcinoma cells (Cong et al, 2016). The gene discussed is EDNRA; the disease is central nervous system cancer.